Medicare Enrolled
Dr. Matthew Fink, M.D.
Medical Oncology · Tampa, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fink from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fink?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fink
Dr. Matthew Fink is a medical oncology specialist in Tampa, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Fink performed 117,632 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Fink received a total of $4,854 from 47 pharmaceutical and/or device companies across 205 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fink is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 21% volume in FL
$4,854 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 89478 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗117,632
Medicare services
Top 21% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
37,740 | $0 | $4 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
31,000 | $0 | $5 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
13,201 | $6 | $23 |
| Anti-nausea injection (aprepitant) | 9,490 | $1 | $5 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
7,080 | $0 | $2 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
4,985 | $0 | $1 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,166 | $0 | $3 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,907 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,875 | $8 | $9 |
| Denosumab injection (Prolia/Xgeva) | 1,500 | $18 | $51 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,244 | $93 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 950 | $1 | $28 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
709 | $10 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 588 | $0 | $9 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
492 | $12 | $61 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
345 | $97 | $378 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
315 | $47 | $189 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
260 | $1 | $6 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
205 | $22 | $84 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
179 | $7 | $69 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
178 | $21 | $79 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
174 | $1 | $3 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
154 | $17 | $59 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
86 | $10 | $42 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
75 | $3 | $11 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
67 | $2 | $8 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
62 | $15 | $56 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
58 | $2 | $7 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
54 | $139 | $474 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
53 | $123 | $453 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
49 | $1,096 | $3,706 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 48 | $401 | $680 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
47 | $54 | $344 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
47 | $66 | $239 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
44 | $168 | $550 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
40 | $48 | $178 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
38 | $28 | $156 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
29 | $24 | $156 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
23 | $4 | $10 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
22 | $55 | $350 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
20 | $70 | $277 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
19 | $1 | $7 |
| New patient office visit, complex (60-74 min) | 14 | $173 | $585 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
33.0% high complexity
62.3% medium
4.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,854
Total received (2018-2024)
Avg $693/year across 7 years
Bottom 43% in FL for medical oncology
47
Companies
205
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,657
2023
$1,372
2022
$980
2021
$121
2020
$45
2019
$344
2018
$336
Payments by company (2024)
PFIZER INC.
$502
Bayer Healthcare Pharmaceuticals Inc.
$134
Novartis Pharmaceuticals Corporation
$99
Celgene Corporation
$99
Mirati Therapeutics, Inc.
$90
Gilead Sciences, Inc.
$89
E.R. Squibb & Sons, L.L.C.
$87
ABBVIE INC.
$73
TerSera Therapeutics LLC
$70
Daiichi Sankyo Inc.
$58
SpringWorks Therapeutics, Inc.
$55
Tempus AI, Inc
$53
GENZYME CORPORATION
$48
Merck Sharp & Dohme LLC
$42
GlaxoSmithKline, LLC.
$38
ARRAY BIOPHARMA INC
$24
Boston Scientific Corporation
$23
BeiGene USA, Inc.
$23
Eisai Inc.
$21
Astellas Pharma US Inc
$17
TAIHO ONCOLOGY, INC.
$14
Top 3 companies account for 44.3% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$606
PFIZER INC.
$573
E.R. Squibb & Sons, L.L.C.
$441
Gilead Sciences, Inc.
$338
Novartis Pharmaceuticals Corporation
$312
Daiichi Sankyo Inc.
$293
Sirtex Medical Inc
$185
Bayer Healthcare Pharmaceuticals Inc.
$157
Janssen Biotech, Inc.
$150
Merck Sharp & Dohme LLC
$145
GENZYME CORPORATION
$126
TerSera Therapeutics LLC
$110
ABBVIE INC.
$107
GlaxoSmithKline, LLC.
$94
Mirati Therapeutics, Inc.
$90
Pharmacyclics LLC, An AbbVie Company
$82
BeiGene USA, Inc.
$81
AstraZeneca Pharmaceuticals LP
$64
EISAI INC.
$58
Myriad Genetic Laboratories, Inc.
$55
SpringWorks Therapeutics, Inc.
$55
Tempus AI, Inc
$53
Seagen Inc.
$48
Boston Scientific Corporation
$46
Pharmacyclics LLC, an AbbVie Company
$45
AbbVie Inc.
$43
Genentech USA, Inc.
$40
GE HealthCare
$36
CSL Behring
$36
NanoString Technologies, Inc.
$36
TAIHO ONCOLOGY, INC.
$29
TESARO, Inc.
$28
Exelixis Inc.
$27
PUMA BIOTECHNOLOGY, INC.
$26
Telix Pharmaceuticals
$25
ARRAY BIOPHARMA INC
$24
Acrotech Biopharma LLC
$24
PharmaEssentia USA Corporation
$23
Medtronic, Inc.
$21
Eisai Inc.
$21
G1 Therapeutics, Inc.
$19
Astellas Pharma US Inc
$17
Bayer HealthCare Pharmaceuticals Inc.
$16
AbbVie, Inc.
$16
EMD Serono, Inc.
$15
ADC Therapeutics America, Inc.
$12
Rigel Pharmaceuticals, Inc.
$5
Top 3 companies account for 33.4% of all-time payments
Associated products mentioned in payments ›
Afstyla · BELEODAQ · BESREMI · BRUKINSA · Bavencio · CABLIVI · CALQUENCE · CEREZYME · CHANTIX · COSELA · Cabometyx · DARZALEX · ELIQUIS · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · Enhertu · Erleada · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INLYTA · INREBIC · Inrebic · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · MOVANTIK · MYRISK · NERLYNX · Nubeqa · OGSIVEO · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION SYSTEM · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · Padcev · Perjeta · Pomalyst · REBLOZYL · Revlimid · Rezlidhia · SARCLISA · SIR-Spheres Microspheres · SPRYCEL · TECENTRIQ · TECVAYLI · TUKYSA · Trodelvy · VENCLEXTA · VOTRIENT · Venclexta · WaveWriter Alpha Prime 16 · XT CDX · XTANDI · ZEJULA · ZOLADEX · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
65
County median income
$75,011
Nearest hospital to ZIP centroid (approximate)
ST JOSEPHS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fink is a mixed practice specialist, with above-average Medicare volume (top 21% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fink experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Fink performed 37,740 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Fink receive payments from pharmaceutical companies?
Yes. Dr. Fink received a total of $4,854 from 47 companies across 205 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fink's costs compare to other medical oncologists in Tampa?
Dr. Fink's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fink) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Tampa
Browse medical oncologists in Tampa ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology